Clinical Trials Logo
  1. Home
  2. Hair Loss/Baldness
  3. NCT05296863

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

Alopecia, Androgenetic Clinical Trial

Official title:
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia: A Randomized, Double-blind Clinical Trial

Clinical Trial Summary

This study investigated the efficacy of adipose derived stem cell conditioned media (ADSC-CM) combined with minoxidil for hair regeneration therapy in male AGA.

Clinical Trial Description

This study was a double-blind, randomized clinical trial (RCT). Two concentrations of ADSC-CM were utilized: concentrated and non-concentrated ADSC-CM. The scalp was divided vertically in half; one side was injected with 2 ml of ADSC-CM, while the control side received 2 ml of NaCl 0,9%. After the injection, patients applied topical 5% minoxidil twice daily. Clinical improvements were assessed using photographic evaluation and trichoscan every two weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05296863
Study type Interventional
Source Indonesia University
Contact
Status Completed
Phase Phase 3
Start date October 11, 2021
Completion date December 3, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT01189279 - Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia Phase 1
Completed NCT02503852 - STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia N/A
Completed NCT05802173 - Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia Phase 2
Not yet recruiting NCT03154528 - Role of Vitamin D in Androgenetic Alopecia
Terminated NCT02676310 - Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) Phase 1
Recruiting NCT05910450 - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss Phase 3
Completed NCT01325337 - Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia Phase 2
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Recruiting NCT06263413 - Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Recruiting NCT05681897 - Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia N/A
Completed NCT05244980 - A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA) Phase 1
Completed NCT01904721 - A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA) Phase 2
Completed NCT03004469 - Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia Phase 3
Recruiting NCT05914805 - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2) Phase 3
Completed NCT04913519 - A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) Phase 1